Stelac Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-600
Closed -$164K 136
2018
Q1
$164K Hold
600
0.05% 80
2017
Q4
$191K Hold
600
0.08% 48
2017
Q3
$188K Hold
600
0.06% 62
2017
Q2
$163K Hold
600
0.05% 56
2017
Q1
$164K Buy
+600
New +$170K 0.05% 62

Other funds holding BIIB

Stelac Advisory Services's BIIB Position: Q2 2018 in Review

Stelac Advisory Services sold out of Biogen (BIIB) in Q2 2018, closing a stake of 600 shares — an estimated $164K sold.

Stelac Advisory Services first reported a position in BIIB in Q1 2017 and held it in 5 quarters. The position peaked at $191K in Q4 2017. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Stelac Advisory Services reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Stelac Advisory Services sold 600 Biogen shares in Q2 2018, an estimated $164K.
  • Stelac Advisory Services first reported a position in Biogen in Q1 2017 and held it in 5 quarters.
  • Stelac Advisory Services's Biogen position peaked at $191K in Q4 2017.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Stelac Advisory Services's 13F filing for Q2 2018, filed 19 Jul 2018.